PMH19 COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES

May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.1064
https://www.valueinhealthjournal.com/article/S1098-3015(19)31256-2/fulltext
Section Title :
Section Order : 10595
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31256-2&doi=10.1016/j.jval.2019.04.1064
HEOR Topics :
Tags :
Regions :